Escient Pharmaceuticals picks up Series B
San Diego-based Escient Pharmaceuticals Inc, a biotech firm, has secured $77.5 million in Series B financing.
14 September 2020•1 min read
San Diego-based Escient Pharmaceuticals Inc, a biotech firm, has secured $77.5 million in Series B financing.